These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4507068)

  • 1. Qualitative and quantitative report on chlorpromazine and metabolites in plasma, erythrocytes and erythrocyte washings from chronically medicated schizophrenic patients.
    Turano P; March JE; Turner WJ; Merlis S
    J Med; 1972; 3(2):109-20. PubMed ID: 4507068
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitation of chlorpromazine and its metabolites in human plasma and urine by direct spectrodensitometry of thin-layer chromatograms.
    Chan TL; Sakalis G; Gershon S
    Adv Biochem Psychopharmacol; 1974; 9(0):323-33. PubMed ID: 4836209
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of chlorpromazine and thioridazine metabolites in human erythrocytes.
    Zingales IA
    J Chromatogr; 1969 Nov; 44(3):547-62. PubMed ID: 4311408
    [No Abstract]   [Full Text] [Related]  

  • 4. Thin-layer chromatography of chlorpromazine metabolites. Attempt to identify each of the metabolites appearing in blood, urine and feces of chronically medicated schizophrenics.
    Turano P; Turner WJ; Manian AA
    J Chromatogr; 1973 Jan; 75(2):277-93. PubMed ID: 4701542
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma-level studies of chlorpromazine following the administration of chlorpromazine hydrochloride and chlorpromazine embonate in chronic schizophrenics.
    Cooper SF; Albert JM; Hillel J; Caille G
    Curr Ther Res Clin Exp; 1973 Feb; 15(2):73-7. PubMed ID: 4632509
    [No Abstract]   [Full Text] [Related]  

  • 6. Dehalogenation and N-dealkylation of chlorpromazine as revealed by plasma concentrations of metabolites in a population of chronically medicated schizophrenics.
    Valoti M; Palmi M; Della Corte L; Nardini M; Corti P; Sgaragli GP
    Methods Find Exp Clin Pharmacol; 1992; 14(6):445-50. PubMed ID: 1469953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha methyldopa-chlorpromazine interaction in schizophrenic patients.
    Chouinard G; Pinard G; Prenoveau Y; Tetreault L
    Curr Ther Res Clin Exp; 1973 Feb; 15(2):60-72. PubMed ID: 4632508
    [No Abstract]   [Full Text] [Related]  

  • 8. Interpatient variation and significance of plasma levels of chlorpromazine in psychotic patients.
    March JE; Donato D; Turano P; Turner WJ
    J Med; 1972; 3(3):146-62. PubMed ID: 4508254
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of a quaternary ammonium-linked glucuronide of chlorpromazine in the urine of a schizophrenic patient treated with chlorpromazine.
    Chaudhary AK; Hubbard JW; McKay G; Midha KK
    Drug Metab Dispos; 1988; 16(3):506-8. PubMed ID: 2900749
    [No Abstract]   [Full Text] [Related]  

  • 10. Chlorpromazine plasma levels, adverse effects, and tobacco smoking: case report.
    Stimmel GL; Falloon IR
    J Clin Psychiatry; 1983 Nov; 44(11):420-2. PubMed ID: 6643405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in "overinclusive" thinking of schizophrenic patients is related to plasma phenothiazine concentration.
    Phillipson OT; Baker J; Williams M
    Adv Biochem Psychopharmacol; 1980; 24():591-7. PubMed ID: 6105805
    [No Abstract]   [Full Text] [Related]  

  • 12. Chlorpromazine metabolism. II. Determination of nonconjugated metabolites in blood of schizophrenic patients.
    Kaul PN; Conway MW; Ticku MK; Clark ML
    J Pharm Sci; 1972 Apr; 61(4):581-5. PubMed ID: 5014315
    [No Abstract]   [Full Text] [Related]  

  • 13. Chlorpromazine metabolism and clinical response in acute schizophrenia: a preliminary report.
    Schooler NR; Sakalis G; Chan TL
    Psychopharmacol Bull; 1975 Oct; 11(4):30-3. PubMed ID: 1105639
    [No Abstract]   [Full Text] [Related]  

  • 14. Chlorpromazine in chronic schizophrenia. The effect of age and hospitalization on behavioral dose-response relationships.
    Clark ML; Ramsey HR; Rahhal DK; Serafetinides EA; Wood FD; Costiloe JP
    Arch Gen Psychiatry; 1972 Oct; 27(4):479-83. PubMed ID: 5072717
    [No Abstract]   [Full Text] [Related]  

  • 15. The possible role of metabolites in therapeutic response to chlorpromazine treatment.
    Sakalis G; Chan TL; Gershon S; Park S
    Psychopharmacologia; 1973 Sep; 32(3):279-84. PubMed ID: 4762235
    [No Abstract]   [Full Text] [Related]  

  • 16. Radioreceptor assay of neuroleptics in refractory chronic schizophrenic patients.
    Lindenmayer JP; Smith D; Katz I
    J Clin Psychiatry; 1984 Mar; 45(3):117-9. PubMed ID: 6142035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorpromazine metabolism. V. Disposition of free and conjugated metabolites in blood fractions of schizophrenic patients.
    Kaul PN; Ticku MK; Clark ML
    J Pharm Sci; 1972 Nov; 61(11):1753-7. PubMed ID: 4652645
    [No Abstract]   [Full Text] [Related]  

  • 18. A possible mechanism for the antischizophrenic action of chlorpromazine: inhibition of the formation of dimethyltryptamine by chlorpromazine metabolites.
    Narasimhachari N; Lin RL
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):341-51. PubMed ID: 4527612
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in erythrocyte shape in children treated with chlorpromazine].
    BichoĊ„ski R; Tabarowski Z; Dabrowski Z
    Folia Med Cracov; 1992; 33(1-4):59-64. PubMed ID: 1343002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of medical treatment on the antithymic activity of schizophrenic patients' serum].
    Domashneva IV; Minsker EI; Panteleeva GP; Tsirkin SIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(8):1199-1203. PubMed ID: 6976054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.